scholarly journals RECENT ADVANCES IN T-CELL LYMPHOID NEOPLASMS

Author(s):  
Anna Bigas ◽  
Juan José Rodriguez-Sevilla ◽  
Lluis Espinosa ◽  
Fernando Gallardo
F1000Research ◽  
2016 ◽  
Vol 5 ◽  
pp. 2344 ◽  
Author(s):  
Preeti Sharma ◽  
David M. Kranz

Adoptive T-cell therapies have shown exceptional promise in the treatment of cancer, especially B-cell malignancies. Two distinct strategies have been used to redirect the activity of ex vivo engineered T cells. In one case, the well-known ability of the T-cell receptor (TCR) to recognize a specific peptide bound to a major histocompatibility complex molecule has been exploited by introducing a TCR against a cancer-associated peptide/human leukocyte antigen complex. In the other strategy, synthetic constructs called chimeric antigen receptors (CARs) that contain antibody variable domains (single-chain fragments variable) and signaling domains have been introduced into T cells. Whereas many reviews have described these two approaches, this review focuses on a few recent advances of significant interest. The early success of CARs has been followed by questions about optimal configurations of these synthetic constructs, especially for efficacy against solid tumors. Among the many features that are important, the dimensions and stoichiometries of CAR/antigen complexes at the synapse have recently begun to be appreciated. In TCR-mediated approaches, recent evidence that mutated peptides (neoantigens) serve as targets for endogenous T-cell responses suggests that these neoantigens may also provide new opportunities for adoptive T-cell therapies with TCRs.


2018 ◽  
Vol 23 (9) ◽  
pp. 1039-1053 ◽  
Author(s):  
Kamel Laribi ◽  
Mustapha Alani ◽  
Catherine Truong ◽  
Alix Baugier de Materre

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Ruihao Huang ◽  
Xiaoping Li ◽  
Yundi He ◽  
Wen Zhu ◽  
Lei Gao ◽  
...  

Blood ◽  
1989 ◽  
Vol 74 (3) ◽  
pp. 1073-1083 ◽  
Author(s):  
MJ Dyer

Abstract Rearrangements within the T-cell receptor (TCR)delta/alpha locus were analyzed in a wide variety of lymphoid neoplasms by eight DNA probes specific for TCR J delta, J alpha and C alpha segments. In all 11 T- cell malignancies, rearrangement and/or deletion of TCR delta was detected irrespective of the stage of maturation of the tumor. The organization of TCR delta correlated with the phenotype of the tumor: In “prethymic” T-cell acute lymphocytic leukemia (ALL), TCR delta was the only TCR gene to be rearranged. More mature T cell malignancies expressing CD4 together with CD3 showed deletion of both alleles of TCR delta, suggestive of TCR V alpha-J alpha rearrangement. All 43 B-cell tumors expressing surface immunoglobulin (sIg), including two cases of adult B-cell ALL, had germline configuration of TCR delta/alpha. In contrast, all 17 B-cell precursor ALLs (null, common, and pre-B-cell ALLs) had rearrangement and/or deletion of TCR delta/alpha. A single case of “histiocytic” lymphoma also showed biallelic deletion of TCR delta. Oligoclonal rearrangements of Ig and TCR genes were observed in two cases of B-cell precursor ALL and in one case of T-cell lymphoblastic lymphoma. Patterns of such “aberrant” TCR rearrangement were similar to those observed in T-lineage malignancies. In particular, seven of eight cases of B-cell precursor ALL and the histiocytic lymphoma which demonstrated biallelic TCR delta deletion, (suggestive of a V alpha-J alpha rearrangement) had clonal TCR beta rearrangement. These data support the hypothesis that supposedly aberrant rearrangements of the TCR genes may follow the same developmental controls as found in T-cell differentiation, despite the lack of evidence for further commitment to the T-cell lineage. TCR delta rearrangement is a useful marker of clonality of immature T-cell tumors which may have only this gene rearranged but is not specific to the T-cell lineage.


2012 ◽  
Vol 145 (1-2) ◽  
pp. 402-409 ◽  
Author(s):  
Hiroyuki Mochizuki ◽  
Kenji Nakamura ◽  
Hirofumi Sato ◽  
Yuko Goto-Koshino ◽  
Masahiko Sato ◽  
...  

2016 ◽  
Vol 176 (5) ◽  
pp. 688-704 ◽  
Author(s):  
Rayne H. Rouce ◽  
Sandhya Sharma ◽  
Mai Huynh ◽  
Helen E. Heslop

Sign in / Sign up

Export Citation Format

Share Document